logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
01/02/2026
India will allocate 100 billion rupees to the biopharmaceutical industry in the next five years, and India's Nifty Pharma index has risen by 0.9%.
Latest
4 m ago
According to a report released by Xinda Securities on February 1st, Hars (002615.SZ) has been given a "buy" rating. The main reasons for the rating include: 1) the company released its 25-year performance forecast; 2) the order outlook is optimistic, and profitability is expected to recover; 3) the brand has vast imagination space and is expected to become an important increment. (Daily Economic News)
15 m ago
The Indian stock market extended losses, with the Indian NIFTY50 index falling over 2%, the defense index dropping over 8%, public sector bank index falling by 6%, financial services index and automobile index dropping by 2.5%, and the oil and gas index declining by 2.1%.
18 m ago
The Indian Nifty Midcap 100 index fell by 3.3%.
18 m ago
CITIC Securities: Focus on the opportunity to allocate the pullback window of the copper sector
18 m ago
CITIC Securities: Some assets have long-term logic that is difficult to change due to the impact of external factors.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.